These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36580362)

  • 1. General Practice Patients' Experiences and Perceptions of the WiserAD Structured Web-Based Support Tool for Antidepressant Deprescribing: Protocol for a Mixed Methods Case Study With Realist Evaluation.
    Coe A; Gunn J; Kaylor-Hughes C
    JMIR Res Protoc; 2022 Dec; 11(12):e42526. PubMed ID: 36580362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding Australian general practice patients' decisions to deprescribe antidepressants in the WiserAD trial: a realist informed approach.
    Coe A; Gunn J; Allnutt Z; Kaylor-Hughes C
    BMJ Open; 2024 Feb; 14(2):e078179. PubMed ID: 38355180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.
    Reeve J; Maden M; Hill R; Turk A; Mahtani K; Wong G; Lasserson D; Krska J; Mangin D; Byng R; Wallace E; Ranson E
    Health Technol Assess; 2022 Jul; 26(32):1-148. PubMed ID: 35894932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deprescribing as a Way to Reduce Inappropriate Use of Drugs for Overactive Bladder in Primary Care (DROP): Protocol for a Cluster Randomized Controlled Trial With an Embedded Explanatory Sequential Mixed Methods Study.
    Soerensen AL; Haase Juhl M; Krogh ML; Grønkjær M; Kristensen JK; Olesen AE
    JMIR Res Protoc; 2024 Jul; 13():e56277. PubMed ID: 39042875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Social media group support for antidepressant deprescribing: a mixed-methods survey of patient experiences.
    Coe A; Abid N; Kaylor-Hughes C
    Aust J Prim Health; 2024 May; 30():. PubMed ID: 38709900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electronic Decision Support for Deprescribing in Patients on Hemodialysis: Clinical Research Protocol for a Prospective, Controlled, Quality Improvement Study.
    Bortolussi-Courval É; Podymow T; Trinh E; Moryousef J; Hanula R; Huon JF; Mavrakanas T; Suri R; Lee TC; McDonald EG
    Can J Kidney Health Dis; 2023; 10():20543581231165712. PubMed ID: 37435299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT.
    Duffy L; Clarke CS; Lewis G; Marston L; Freemantle N; Gilbody S; Hunter R; Kendrick T; Kessler D; King M; Lanham P; Mangin D; Moore M; Nazareth I; Wiles N; Bacon F; Bird M; Brabyn S; Burns A; Donkor Y; Hunt A; Pervin J; Lewis G
    Health Technol Assess; 2021 Nov; 25(69):1-62. PubMed ID: 34842135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A realist evaluation of patients' decisions to deprescribe in the EMPOWER trial.
    Martin P; Tannenbaum C
    BMJ Open; 2017 May; 7(4):e015959. PubMed ID: 28473524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding Whether and How a Digital Health Intervention Improves Transition Care for Emerging Adults Living With Type 1 Diabetes: Protocol for a Mixed Methods Realist Evaluation.
    Wang R; Rouleau G; Booth GL; Brazeau AS; El-Dassouki N; Taylor M; Cafazzo JA; Greenberg M; Nakhla M; Shulman R; Desveaux L
    JMIR Res Protoc; 2023 Sep; 12():e46115. PubMed ID: 37703070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pharmacist integrated into a general practice in Australia: an evolving model of care in medicines optimization.
    Jordan M; Mullan J; Stewart A; Chen TF
    Int J Pharm Pract; 2023 Dec; 31(6):608-616. PubMed ID: 37823732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressant deprescribing: State of the art and recommendations-A literature overview.
    Romagnoli A; Zovi A; Santoleri F; Lasala R
    Eur J Clin Pharmacol; 2024 Mar; 80(3):417-433. PubMed ID: 38189859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimising a person-centred approach to stopping medicines in older people with multimorbidity and polypharmacy using the DExTruS framework: a realist review.
    Turk A; Wong G; Mahtani KR; Maden M; Hill R; Ranson E; Wallace E; Krska J; Mangin D; Byng R; Lasserson D; Reeve J
    BMC Med; 2022 Aug; 20(1):297. PubMed ID: 36042454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deprescribing Opportunities for Hospitalized Patients With End-Stage Kidney Disease on Hemodialysis: A Secondary Analysis of the MedSafer Cluster Randomized Controlled Trial.
    Moryousef J; Bortolussi-Courval É; Podymow T; Lee TC; Trinh E; McDonald EG
    Can J Kidney Health Dis; 2022; 9():20543581221098778. PubMed ID: 35586025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spread and scale of an electronic deprescribing software to improve health outcomes of older adults living in nursing homes: study protocol for a stepped wedge cluster randomized trial.
    Nadeau ME; Henry JL; Lee TC; Bortolussi-Courval É; Goodine C; McDonald EG
    Trials; 2021 Nov; 22(1):763. PubMed ID: 34727956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-reported reasons for reducing or stopping antidepressant medications in primary care: thematic analysis of the
    Coe A; Gunn J; Fletcher S; Murray E; Kaylor-Hughes C
    Prim Health Care Res Dev; 2023 Feb; 24():e16. PubMed ID: 36843079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients' attitudes toward deprescribing and their experiences communicating with clinicians and pharmacists.
    Lukacena KM; Keck JW; Freeman PR; Harrington NG; Huffmyer MJ; Moga DC
    Ther Adv Drug Saf; 2022; 13():20420986221116465. PubMed ID: 36003624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.